Fractionation of the culture supernatant fluids of a cornea-virulent strain of Pseudomonas aeruginosa by ammonium sulfate precipitation, diafiltration, isoelectric focusing, ion-exchange chromatography, gel filtration, and sucrose density gradient centrifugation failed to separate the rabbit cornea-damaging activity and the in vitro protease activity of the preparations. Three proteases having similar molecular weights (approximately 20,000) and isoelectric points of approximately 4.6, 5.8, and 8.8 were obtained free of detectable amounts of other known extracellular pseudomonal enzymes. Heating a mixture of the three proteases for 15 min at 80 C resulted in complete loss of protease and cornea-damaging activities. The sterile culture filtrate of a nonproteolytic but lethal toxin-producing strain of P. aeruginosa did not contain cornea-damaging activity. Cultivation of the proteolytic strain in broth containing 4.7% ammonium sulfate yielded a culture supernatant fluid free of protease and corneadamaging activities. The results obtained support the conclusion that a cornea-virulent strain of P. aeruginosa can produce, in vitro, at least three different extracellular proteases capable of eliciting rapid and extensive damage to rabbit corneas.
Pseudomonas aeruginosa produces an acute and severe corneal infection which progresses rapidly, is difficult to treat, and often results in extensive corneal scarring and visual impairment (10, 19) . The rapidly developing corneal destruction caused by this bacterium also may result in corneal perforation with its attending complications of panophthalmitis. In addition, the infection may become systemic in premature infants and cause their death (8) .
Despite the fact that this bacterium is currently one of the leading causes of central corneal ulcers of bacterial etiology (19) , the mechanism(s) by which it produces corneal pathology is still unclear. Fisher and Allen (11, 12) and Wilson (40) showed that sterile culture filtrates of cornea-virulent strains of P. aeruginosa could, if intracorneally injected, produce damage grossly similar to that observed during corneal infection. The culture filtrates possessing this pharmacological activity were not extensively examined for the presence of the many known extracellular products of P. aeruginosa (16, 41) ; however, they were reported to contain protease and hexapeptidase activities, to digest rat tendon collagen, and to degrade a crude corneal extract thought to contain collagen (11, 12, 35, 40) . The corneadamaging activity was nondialyzable, could be precipitated with ammonium sulfate or ethanol, and was inhibited by disodium ethylenediaminetetraacetate. The active component was believed to be a pseudomonal protease or a collagenase also possessing hexapeptidase activity. However, in view of the fact that past investigators examined relatively crude preparations, which could have contained many different pseudomonal products, the observed pathology could not be rigorously ascribed to a particular enzyme or toxin.
The present study was initiated as a first step toward elucidating the nature and properties of the extracellular products of P. aeruginosa which elicit the fulminating corneal destruction characteristic of pseudomonal corneal infections. Data are presented to show that a corneavirulent strain of P. aeruginosa produces, in vitro, three extracellular proteases capable of causing rapid and extensive damage to rabbit corneas.
MATERIALS AND METHODS
Bacteria and culture media. P. aeruginosa, strain 5-31, isolated from a human corneal infection, was kindly supplied by J. Gerke (14) . P. aeruginosa, strain PA-103, was supplied through the courtesy of P. V.
Liu. This strain produces the pseudomonal lethal toxin in vitro but is a very poor producer of protease (21) . The bacteria were cultivated in tryptone-yeast extract-glucose broth (pH 7.2) containing 0.5% tryptone (Difco), 0.25% yeast extract (Difco or BBL), and 0.1% glucose. Preliminary experiments showed that the 5-31 strain produced an optimal amount of extracellular protease activity when cultivated in this medium. Liu and Hsieh (22) have shown that the presence of ammonium sulfate in the medium inhibits protease production by various bacteria. During our investigation, the ability of ammonium sulfate to inhibit the production of protease and cornea-damaging activities was examined by adding various amounts of a solution of ammonium sulfate (52% wt/vol, pH 7.2), sterilized by membrane filtration, to the medium.
Preparation of extracellular protease concentrate. Two-liter flasks containing 400 ml of tryptoneyeast extract-glucose broth were inoculated with 0.1 ml of a stationary-phase culture of P. aeruginosa, strain 5-31. The medium was incubated for 20 to (38) . The gradient was prepared with (i) a less dense solution consisting of 51.7 ml of water, 0.8 ml of 40% (wt/vol) ampholine (pH 3.5 to 10 or pH 5 to 7; LKB Instruments, Rockville, Md.), and 25 mg of extracellular protease concentrate dissolved in 2.5 ml of 0.02 M Tris-hydrochloride (pH 7.5), and (ii) a more dense solution consisting of 38.8 ml of water, 1.7 ml of 40% (wt/vol) ampholine (pH 3.5 to 10 or pH 5 to 7), and 25 g of sucrose (Schwarz/Mann, ultrapure grade). Focusing was done at 4 C for approximately 46 h in a 110-ml electrolysis column (LKB Instruments) with a final potential of 600 V for the pH 3.5 to 10 gradient, and a final potential of 900 V for the pH 5 to 7 gradient. The pH of each fraction (4 ml) was determined at 4 C, and the fractions were assayed for protease activity. The peak fractions of protease activity were tested for cornea-damaging activity. They were dialyzed, prior to injection, against 0.1 M ammonium bicarbonate (pH 7.8).
Ion-exchange chromatography. Diethylaminoethyl agarose (DEAE Bio-Gel A, Bio-Rad Laboratories, New York, N.Y.) was equilibrated with 0.02 M Tris-hydrochloride (pH 8) and packed in a watercooled (5 C) column (2.6 by 45 cm). After addition of the extracellular protease concentrate (40 mg dissolved in 8 ml of equilibrating buffer) to the column, the column was washed with 411 ml of equilibrating buffer. Gradient elution was performed with a linear gradient maker (Pharmacia Fine Chemicals, Piscataway, N.J.) consisting of a reservoir containing 0.02 M Tris-hydrochloride (pH 7) and 0.5 M NaCl which fed into a constant-volume mixing chamber containing 260 ml of 0.02 M Tris-hydrochloride (pH 7). The constant-volume mixing chamber discharged into the column at a rate of approximately 20 ml/h. After gradient elution, the column was washed with 350 ml of 0.02 M Tris-hydrochloride (pH 7) containing 1 M NaCl. Fractions (5 ml) were collected and assayed for protease activity and absorbance at 280 nm. The peak fractions of protease activity were tested for cornea-VOL. 9, 1974 damaging activity. The elution gradient was measured with a conductivity bridge (model RC-16B2, Beckman Instruments, Cedar Grove, N.J.).
Gel filtration chromatography. Gel filtration was performed with water-cooled (5 C) columns of Sephadex G-75 regular and superfine (Pharmacia) equilibrated with 0.1 M ammonium bicarbonate (pH 7.8). Extracellular protease concentrate (30 mg dissolved in 3 ml of equilibrating buffer) was applied to the columns and eluted, in the upward flow mode, at a flow rate of 12 ml/h (2.3 ml per cm2 per h) with the equilibrating buffer. Fractions (3 ml) were collected and assayed for protease activity and absorbance at 280 nm. The peak fractions of protease activity were tested for cornea-damaging activity. Blue dextran was used to determine the column void volume and the homogeneity of column packing. Apparent molecular weight was estimated by the method of Andrews (2) .
Sucrose density gradient centrifugation. Rate zonal centrifugation in a sucrose density gradient was performed by the method of Martin and Ames (24) . Samples (0.1 ml) were layered onto 5-ml preformed linear gradients of 5 to 20% sucrose (wt/vol) in 0.02 M Tris-hydrochloride (pH 7.5) contained in cellulose nitrate tubes (0.5 by 2.0 inches; ca. 1.3 to 5.1 cm) and were centrifuged (SW-50 rotor, 40,000 rpm, 24 h, 5 C) in a Beckman L2-65B ultracentrifuge. The extracellular protease concentrate (1 mg) and reference proteins (2 mg) were centrifuged in separate tubes, in triplicate, and the contents of each of the tubes were collected in five-drop fractions. The concentrate fractions were assayed for protease activity, and the reference proteins were located by their absorbance at 280 nm. The peak fractions of protease activity were dialyzed against 0.1 M ammonium bicarbonate (pH 7.8) and tested for cornea-damaging activity.
Heat inactivation. The ability of the protease and cornea-damaging activities to resist heat inactivation was examined by heating solutions (0.2 mg/ml; 3 to 4 protease units/ml) of the extracellular protease concentrate in 0.02 M Tris-hydrochloride (pH 7.5) for 15 min at various temperatures, followed by assaying for residual protease and cornea-damaging activity.
RESULTS
Isoelectric focusing. Two peaks of protease activity were observed in the pH 3.5 to 10 gradient system (Fig. 1) . A major peak containing 95% of the recovered activity focused at pH 5.9, and a minor peak focused at approximately pH 8.3 to 8.8. In the pH 5 to 7 gradient system (Fig. 2) Fig. 3 .
Ion-exchange chromatography. Three proteases were separated by ion-exchange chromatography (Fig. 4) . One small peak of protease activity was eluted during the washing of the column with 0.02 M Tris-hydrochloride (pH 8, conductivity at 25 C of 900 mmhos/cm). During the application of the elution gradient, a major peak was eluted at a conductivity of 8,000 mmhos/cm, and a minor peak was eluted at approximately 13,500 mmhos/cm. Solutions (1 to 2 protease units/ml) of the three protease peak fractions produced extensive corneal dam- approximately 95% of the applied activity, was observed (Fig. 5) . The peak was well separated from large amounts of nonproteolytic 280 nmabsorbing material and from a small amount of protease activity which was eluted slightly after the column void volume. Analysis of the large protease peak by isoelectric focusing in a pH 5 to 7 gradient showed the same distribution pattern of three proteases observed when the extracellular protease concentrate was fractionated by electrofocusing. The elution volume of the large peak of protease activity corresponded to an apparent molecular weight of 20,000 (Fig.  6) . A sample of a diluted solution (1 protease unit/ml) of this peak, and of the protease peak eluting near the void volume, produced corneal damage similar to that elicited with the pro--45 3.3 (Fig. 7) . A solution (1 to 2 protease units/ml) of the protease activity peak produced corneal damage similar to that elicited with the proteases isolated by electrofocusing, ion-exchange chromatography, and gel filtration.
Heat inactivation. Heating the extracellular protease concentrate for 15 min at 80 C resulted in complete loss of protease and cornea-damaging activities. Heating for 15 min at 60 C caused a 50% reduction in protease activity; the heated sample produced a smaller lesion by 2 h postinjection than did the unheated preparation.
Protease production and cornea-damaging activity of culture filtrates. Sterile culture filtrates of the proteolytic 5-31 strain contained 1.4 to 1.8 protease units/ml and produced extensive corneal damage similar to that elicited with protease preparations isolated by the various fractionation procedures. Sterile culture filtrates of the PA-103 strain did not contain protease or cornea-damaging activity. When the 5-31 strain was grown in broth containing 4.7% ammonium sulfate, the sterile culture filtrate did not contain protease or cornea-damaging activity.
Examination for other pseudomonal products. Hexapeptidase, collagenase, lecithinase C, esterase, lipase, lipoprotein lipase, deoxyribonuclease, ribonuclease, alkaline phosphatase, hemolysin, and bacteriolytic activities were not detected in cornea-damaging protease preparations obtained by isoelectric focusing. 
DISCUSSION
Partially purified protease preparations of P. aeruginosa have been reported to damage several mammalian tissues (11, 20, 27) ; however, the heterogeneous nature of the preparations has made it difficult to determine whether all the reported in vivo activities are properties of a pseudomonal protease. Five observations described in this communication support the conclusion that a cornea-virulent strain of P. aeruginosa can produce, in vitro, at least three different extracellular proteases capable of eliciting rapid and extensive damage to rabbit corneas. First, physicochemical fractionation of the culture supernatant fluid of a cornea-virulent strain of P. aeruginosa isolated three cornea-damaging proteases having markedly different pl. Second, the proteases were free of detectable amounts of other known extracellular pseudomonal enzymes. Third, heating a mixture of the three proteases for 15 min at 80 C caused complete loss of protease and corneadamaging activities. Fourth, the sterile culture filtrate of a nonproteolytic but lethal toxin-producing strain did not contain cornea-damaging activity. Fifth, in vitro production of protease and cornea-damaging activities was inhibited by ammonium sulfate.
At the present time, we do not know whether the small amount of protease activity which was eluted near the Sephadex G-75 column void volume is indicative of a fourth protease in the preparation, or represents a small amount of one of the other three proteases in an active aggregated or carrier-bound form. Studies are planned to resolve this question.
The knowledge that P. aeruginosa produces cornea-damaging proteases should not, at this time, be construed as suggesting that this bacterium cannot, under the appropriate in vitro or in vivo conditions, synthesize other cornea-damaging products. For example, intracorneal injection of pseudomonal endotoxin causes extensive and persistent corneal opacification (26) . This substance does not, however, elicit the marked colliquative necrosis and corneal perforation characteristically induced by the pseudomonal proteases. Intracorneal injection of Clostridium histolyticum collagenase has been reported (29) to result in degradation of corneal collagen and in corneal perforation; however, the question of whether P. aeruginosa produces a collagenase is unsettled. Adamcic and Clark (1) described the adaptive collagenolytic activity of two pigmented pseudomonads grown in a medium containing soluble chicken skin collagen. The bacteria studied were not identified, however, as strains of P. Kucera and Lysenko (17) claimed to have isolated P. aeruginosa elastases possessing collagenase activity against insoluble calf skin collagen. Morihara et al. (31) did not, however, detect collagenase activity in their pseudomonal elastase preparation. The knowledge that nonspecific proteolytic enzymes active at neutral pH are capable, in vitro, of readily dissolving highly cross-linked tissues such as skin and tendon (34) , and the assay procedure of Kucera and Lysenko suggests that these workers were, in fact, detecting dissolution of collagen fibrils rather than hydrolysis of the collagen backbone structure. Schoellmann and Fisher (35) showed that a strain of P. aeruginosa could produce an extracellular enzyme capable of hydrolyzing a synthetic hexapeptide substrate in a manner identical to the cleavage of the substrate by C. histolyticum collagenase. Waldvogel and Swartz (39) reported, however, that this hexapeptidase was not active against undenatured collagen. Diener et al. (9) reported the production of collagenase by a strain of P. aeruginosa. The enzyme was incubated for 18 h with insoluble bovine tendon collagen, followed by assaying for the release of free amino group-containing peptides (but not hydroxyproline or proline) from the substrate. A number of common proteases are known to produce slow and nonspecific hydrolysis of peptide linkages located at the nonhelical terminal portions of the triple-stranded collagen helix (34) , and thus cause the release of free amino group-containing peptides without attacking the characteristic helical regions of the collagen molecule. Diener et al. may have been detecting this phenomenon with their enzyme preparation, and further kinetic studies and analysis of the reaction end products of their system should be performed before the enzyme can be definitively classified as a true collagenase. We will be examining the possibility tht(t the corneadamaging pseudomonal proteases elicit corneal pathology via an indirect rather than by a direct mechanism of corneal collagen degradation. For example, perhaps the enzymes (i) damage one or more of the corneal cell types and cause them to release collagenase, or (ii) activate an extracellular zymogen form of collagenase normally present in the corneal stroma. Studies are also planned to determine if other known extracellular pseudomonal products possess corneadamaging activity similar to the pseudomonal proteases.
Proteases of pseudomonal origin do not appear to be unique in their ability to damage the mammalian cornea. Fisher and Allen (11) did not observe damage after intracorneal injection of trypsin; however, other investigators (5, 29) subsequently reported that trypsin, papain, Pronase, and a crude protease preparation obtained from polymorphonuclear leucocyte lysosomes possessed cornea-damaging activity.
Several investigators (4, 17, (30) (31) (32) 37 ) have partially characterized the physicochemical properties of some of the multiple proteases of P. aeruginosa. Work is currently in progress to obtain large amounts of homogeneous corneadamaging proteases. The physicochemical properties of these proteases will be compared with those reported for the pseudomonal proteases previously isolated by other workers. Obtaining large amounts of homogeneous cornea-damaging proteases will also enable us to commence studies designed to determine (i) the mechanism(s) by which the enzymes produce corneal pathology, and (ii) the enzymes' role(s) in the pathogenesis of pseudomonal corneal infections. 
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